Sherilyn Tuazon

TitleInstructor
InstitutionThomas Jefferson University
DepartmentMedical Oncology
Address834 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cowan AJ, Stevenson PA, Green DJ, Tuazon S, Libby EN, Kwok M, Lee S, Coffey DG, Gopal AK, Holmberg LA. Prolonged Lenalidomide Therapy Does Not Impact Autologous PBSC Mobilization and Collection in Multiple Myeloma Patients: A Single Center Retrospective Analysis. Transplant Cell Ther. 2021 Apr 22. PMID: 33895403.
      Citations:    
    2. Cowan AJ, Tuazon SA, Portuguese AJ, Green DJ. Chimeric Antigen Receptor T Cells for Multiple Myeloma: The Journey So Far-And the Road Ahead. Cancer J. 2021 Mar-Apr 01; 27(2):112-118. PMID: 33750070.
      Citations:    
    3. Tuazon SA, Holmberg LA, Nadeem O, Richardson PG. A clinical perspective on plasma cell leukemia; current status and future directions. Blood Cancer J. 2021 Feb 04; 11(2):23. PMID: 33563906.
      Citations:    
    4. Tuazon SA, Cassaday RD, Gooley TA, Sandmaier BM, Holmberg LA, Smith SD, Maloney DG, Till BG, Martin DB, Chow VA, Rajendran JG, Fisher DR, Matesan MC, Lundberg SJ, Green DJ, Pagel JM, Press OW, Gopal AK. Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma. Biol Blood Marrow Transplant. 2020 Sep 25. PMID: 32980545.
      Citations:    
    5. Tuazon SA, Sandmaier BM, Gooley TA, Fisher DR, Holmberg LA, Becker PS, Lundberg SJ, Orozco JJ, Gopal AK, Till BG, Coffey DG, Nartea ME, Matesan MC, Pagel JM, Rajendran JG, Press OW, Bensinger WI, Green DJ. 90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma. Bone Marrow Transplant. 2020 Jul 24. PMID: 32710011.
      Citations:    
    6. Cowan AJ, Green DJ, Karami M, Becker PS, Tuazon S, Coffey DG, Hyun TS, Libby EN, Gopal AK, Holmberg LA. KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2020 Apr 14. PMID: 32457024.
      Citations:    
    7. O'Steen S, Comstock ML, Orozco JJ, Hamlin DK, Wilbur DSS, Jones JC, Kenoyer A, Nartea ME, Lin Y, Miller BW, Gooley TA, Tuazon SA, Till BG, Gopal AK, Sandmaier BM, Press OW, Green DJ. The Alpha Emitter Astatine-211 Targeted to CD38 can Eradicate Multiple Myeloma in a Disseminated Disease Model. Blood. 2019 Aug 08. PMID: 31395601.
      Citations:    
    8. Chen J, Pan J, Zhan T, Tuazon S, Saini N, O'Hara W, Filicko-O'Hara J, Klumpp T, Kasner M, Carabasi M, Porcu P, Wagner JL. Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters. Biol Blood Marrow Transplant. 2019 Jun 04. PMID: 31173899.
      Citations:    
    9. Tuazon SA, Li A, Gooley T, Eunson TW, Maloney DG, Turtle CJ, Linenberger ML, Connelly-Smith LS. Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignancies. Transfusion. 2019 Feb 06. PMID: 30729531.
      Citations:    
    10. Cowan AJ, Klippel ZK, Stevenson PA, Hyun TS, Tuazon S, Becker PS, Green DJ, Holmberg LA, Coffey DG, Gopal AK, Libby EN. Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation. Amyloid. 2016 Dec; 23(4):254-259. PMID: 27879147.
      Citations:    
    11. Non L, Sta Cruz JP, Tuazon S. Sudden death in a patient with bone marrow transplant by a fungus among us. BMJ Case Rep. 2014; 2014. PMID: 25391828.
      Citations:    
    Co-Authors (7)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _